Literature DB >> 1668180

Phosphorothioate oligodeoxynucleotides--anti-sense inhibitors of gene expression?

C A Stein1, J L Tonkinson, L Yakubov.   

Abstract

Phosphorothioate (PS) oligodeoxynucleotides are relatively nuclease resistant, water soluble analogs of phosphodiester (PO) oligodeoxynucleotides. These molecules are chiral but still hybridize well to their RNA targets. While considered for use as in vivo anti-sense inhibitors of gene expression, their biology, especially in the anti-viral area, is dominated by non-sequence specific effects. This review discusses both the sequence and non-sequence specific biologic effects of PS oligomers, and attempts to more clearly indicate their ultimate therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1668180     DOI: 10.1016/0163-7258(91)90032-h

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  22 in total

1.  Oligodeoxynucleoside phosphoramidates (P-NH2): synthesis and thermal stability of duplexes with DNA and RNA targets.

Authors:  S Peyrottes; J J Vasseur; J L Imbach; B Rayner
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

Review 2.  Application of antisense DNA method for the study of molecular bases of brain function and behavior.

Authors:  S Ogawa; D W Pfaff
Journal:  Behav Genet       Date:  1996-05       Impact factor: 2.805

3.  Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA.

Authors:  U Koppelhus; V Zachar; P E Nielsen; X Liu; J Eugen-Olsen; P Ebbesen
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

4.  In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.

Authors:  O Vidalin; M E Major; B Rayner; J L Imbach; C Trépo; G Inchauspé
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

5.  New efficient sulfurizing reagents for the preparation of oligodeoxyribonucleotide phosphorothioate analogues.

Authors:  V A Efimov; A L Kalinkina; O G Chakhmakhcheva; T S Hill; K Jayaraman
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

6.  Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.

Authors:  J Lisziewicz; D Sun; V Metelev; P Zamecnik; R C Gallo; S Agrawal
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent.

Authors:  L Benimetskaya; J L Tonkinson; M Koziolkiewicz; B Karwowski; P Guga; R Zeltser; W Stec; C A Stein
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

8.  Uptake and distribution of fluorescein-labeled D2 dopamine receptor antisense oligodeoxynucleotide in mouse brain.

Authors:  S P Zhang; L W Zhou; M Morabito; R C Lin; B Weiss
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

9.  Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.

Authors:  J Lisziewicz; D Sun; F F Weichold; A R Thierry; P Lusso; J Tang; R C Gallo; S Agrawal
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

10.  Phosphorothioate oligonucleotides inhibit the replication of lentiviruses and type D retroviruses, but not that of type C retroviruses.

Authors:  D Archambault; C A Stein; J S Cohen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.